-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
G1 Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2024.
- G1 Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending March 31, 2024 was -0.2 USD/shares, a 62.3% increase year-over-year.
- G1 Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending March 31, 2024 was -0.6 USD/shares, a 78.3% increase year-over-year.
- G1 Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.93 USD/shares, a 72.5% increase from 2022.
- G1 Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -3.38 USD/shares, a 4.52% increase from 2021.
- G1 Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -3.54 USD/shares, a 35.1% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)